Literature DB >> 17194904

Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease.

Paul A Heidenreich1, Ingela Schnittger, H William Strauss, Randall H Vagelos, Byron K Lee, Carol S Mariscal, David J Tate, Sandra J Horning, Richard T Hoppe, Steven L Hancock.   

Abstract

PURPOSE: Incidental cardiac irradiation during treatment of thoracic neoplasms has increased risks for subsequent acute myocardial infarction or sudden cardiac death. Identifying patients who have a high risk for a coronary event may decrease morbidity and mortality. The objective of this study was to evaluate whether stress imaging can identify severe, unsuspected coronary stenoses in patients who had prior mediastinal irradiation for Hodgkin's disease. PATIENTS AND METHODS: We enrolled 294 outpatients observed at a tertiary care cancer treatment center after mediastinal irradiation doses 35 Gy for Hodgkin's disease who had no known ischemic cardiac disease. Patients underwent stress echocardiography and radionuclide perfusion imaging at one stress session. Coronary angiography was performed at the discretion of the physician.
RESULTS: Among the 294 participants, 63 (21.4%) had abnormal ventricular images at rest, suggesting prior myocardial injury. During stress testing, 42 patients (14%) developed perfusion defects (n = 26), impaired wall motion (n = 8), or both abnormalities (n = 8). Coronary angiography showed stenosis 50% in 22 patients (55%), less than 50% in nine patients (22.5%), and no stenosis in nine patients (22.5%). Screening led to bypass graft surgery in seven patients. Twenty-three patients developed coronary events during a median of 6.5 years of follow-up, with 10 acute myocardial infarctions (two fatal).
CONCLUSION: Stress-induced signs of ischemia and significant coronary artery disease are highly prevalent after mediastinal irradiation in young patients. Stress testing identifies asymptomatic individuals at high risk for acute myocardial infarction or sudden cardiac death.

Entities:  

Mesh:

Year:  2007        PMID: 17194904     DOI: 10.1200/JCO.2006.07.0805

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  77 in total

1.  Severe left main coronary stenosis in a young female patient, 6 years after mediastinal radiation therapy for non-Hodgkin lymphoma: assessment by coronary angiography and intravascular ultrasound.

Authors:  Grigorios Korosoglou; Arnt V Kristen; Martin Andrassy; Hugo A Katus; Stefan E Hardt
Journal:  Clin Res Cardiol       Date:  2012-04       Impact factor: 5.460

Review 2.  State-of-the-art issues in Hodgkin's lymphoma survivorship.

Authors:  Shrujal S Baxi; Matthew J Matasar
Journal:  Curr Oncol Rep       Date:  2010-11       Impact factor: 5.075

3.  Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer.

Authors:  Mary Feng; Jean M Moran; Todd Koelling; Aamer Chughtai; June L Chan; Laura Freedman; James A Hayman; Reshma Jagsi; Shruti Jolly; Janice Larouere; Julie Soriano; Robin Marsh; Lori J Pierce
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-24       Impact factor: 7.038

Review 4.  Late effects of therapy for Hodgkin's lymphoma.

Authors:  Michael Jacob Adams; Louis S Constine; Steven E Lipshultz
Journal:  Curr Hematol Malig Rep       Date:  2007-07       Impact factor: 3.952

Review 5.  Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training.

Authors:  Anthony F Yu; Lee W Jones
Journal:  Future Cardiol       Date:  2015-08-03

Review 6.  An update on cardio-oncology.

Authors:  Joerg Herrmann; Amir Lerman
Journal:  Trends Cardiovasc Med       Date:  2014-07-22       Impact factor: 6.677

7.  Cardioprotective effect of zingerone against oxidative stress, inflammation, and apoptosis induced by cisplatin or gamma radiation in rats.

Authors:  Ahmed F Soliman; Lobna M Anees; Doaa M Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-07       Impact factor: 3.000

8.  The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy.

Authors:  Isis Gayed; Salman Gohar; Zhongxing Liao; Mary McAleer; Roland Bassett; Syed Wamique Yusuf
Journal:  Int J Cardiovasc Imaging       Date:  2009-02-22       Impact factor: 2.357

9.  The evolution of proton beam therapy: Current and future status.

Authors:  Xiufang Tian; Kun Liu; Yong Hou; Jian Cheng; Jiandong Zhang
Journal:  Mol Clin Oncol       Date:  2017-11-14

Review 10.  Arterial events in cancer patients-the case of acute coronary thrombosis.

Authors:  Ohad Oren; Joerg Herrmann
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.